AGIO

#1985
Agios Pharmaceuticals, Inc.
33.2350 USD
+0.26%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
33.1500
33.2700
년간 변동
22.2400
45.9900
일일 변동
+0.26%
월간 변동
+19.94%
6달 변화
-23.40%
년간 변동율
-23.40%
이전 종가
33.1500
Open
33.1900
Bid
Ask
Low
33.1500
High
33.2700
양
16
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 1.9473 B
  • Employee 540
  • Founded 2008
  • CEO N/A
  • Website www.agios.com
  • Headquarter Delaware, United States
  • FIGI BBG000QY4ZD0
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.82
Price to sales ratio
29.21

Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

뉴스